Literature DB >> 2786041

Recombinant vaccinia viruses and the development of immunization strategies using influenza virus.

P C Doherty1, W Allan, D B Boyle, B E Coupar, M E Andrew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2786041     DOI： 10.1093/infdis/159.6.1119

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus.

Authors:  Mahesh Khatri; Varun Dwivedi; Steven Krakowka; Cordelia Manickam; Ahmed Ali; Leyi Wang; Zhuoming Qin; Gourapura J Renukaradhya; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

2.  Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice.

Authors:  Y Miyahira; A García-Sastre; D Rodriguez; J R Rodriguez; K Murata; M Tsuji; P Palese; M Esteban; F Zavala; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

4.  Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.

Authors:  C M Lawson; J R Bennink; N P Restifo; J W Yewdell; B R Murphy
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.

Authors:  S J Kent; A Zhao; S J Best; J D Chandler; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus.

Authors:  Samita Andreansky; Haiyan Liu; Heiko Adler; Ulrich H Koszinowski; Stacey Efstathiou; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

7.  Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.

Authors:  Toru Ichihashi; Reiko Yoshida; Chihiro Sugimoto; Ayato Takada; Kiichi Kajino
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

Review 8.  The virus-immunity ecosystem.

Authors:  P C Doherty; S J Turner
Journal:  Arch Virol Suppl       Date:  2005

9.  Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.

Authors:  D Moskophidis; D Kioussis
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.